SEARCH

SEARCH BY CITATION

References

  • 1
    Soffietti R,Costanza A,Laguzzi E, et al. Radiotherapy and chemotherapy of brain metastases. J Neurooncol. 2005; 75: 31-42.
  • 2
    Richards GM,Khuntia D,Mehta MP. Therapeutic management of metastatic brain tumors. Crit Rev Oncol Hematol. 2007; 61: 70-78.
  • 3
    Andrews DW,Scott CB,Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with 1 to 3 brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet. 2004; 363: 1665-1672.
  • 4
    Kamath R,Ryken TC,Meeks SL, et al. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat Oncol Biol Phys. 2005; 61: 1467-1472.
  • 5
    Hall EJ,Brenner DJ. The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys. 1993; 25: 381-385.
  • 6
    Manning MA,Cardinale RM,Benedict SH, et al. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys. 2000; 47: 603-608.
  • 7
    Aoki M,Abe Y,Hatayama Y, et al. Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than 3 metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys. 2006; 64: 414-418.
  • 8
    Lindvall P,Bergstrom P,Lofroth P, et al. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys. 2005; 61: 1460-1466.
  • 9
    Gaspar L,Scott C,Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37: 745-751.
  • 10
    MacDonald DR,Cascino TL,Schold SC, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990; 8: 1277-1280.
  • 11
    Kondziolka D,Patel A,Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999; 45: 427-434.
  • 12
    Ernst-Stecken A,Ganslandt O,Lambrecht U, et al. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol. 2006; 81: 18-24.
  • 13
    Schomas DA,Roeske JC,MacDonald RL, et al. Predictors of tumor control in patients treated with linac-based stereotactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol. 2005; 28: 180-187.
  • 14
    Varlotto JM,Flickinger JC,Niranjan A, et al. Analysis of tumor control and toxicity in patients who have survived at least 1 year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2003; 57: 452-464.
  • 15
    Aoyama H,Shirato H,Onimaru R, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys. 2003; 56: 793-800.
  • 16
    Shepherd SF,Laing RW,Cosgrove VP, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 1997; 43: 291-298.
  • 17
    Shaw M,Scott C,Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000; 47: 291-298.
  • 18
    Vordermark D,Kolbl O,Ruprecht K, et al. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer. 2005; 5: 55.
  • 19
    Manon R,O'Neill A,Knisely J, et al. Phase II trial of radiosurgery for 1 to 3 newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol. 2005; 23: 8870-8876.